Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.
If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.
* Price is subject to applicable taxes.
Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.
(TheNewswire)
Vancouver, British Columbia – TheNewswire - October 3, 2022. Lexston Life Sciences Corp. (CSE:LEXT), (OTC:LEXTF) (“Lexston”) granted 3,000,000 stock options to its directors, officers, consultants, and employees.
Each stock option is exercisable at $0.05 per share. The options vest immediately and expire on October 3, 2027.
All options were granted pursuant to the 10% rolling stock option plan of Lexston dated January 15, 2021 (the “Plan”).
As of the date of this news release Lexston has 3,000,000 stock options granted and 30,917 stock options available for future grants.
About Lexston Life Sciences Corp.
Lexston Life Sciences Corp. has been active in establishing strategic relationships towards executing the goal of acquiring assets and businesses. Lexston has purchased two companies that provide cannabis testing and research services.
On Behalf of the Board of Directors
LEXSTON LIFE SCIENCES CORP.
Jagdip Bal Chief Executive Officer
Telephone: (604) 928-8913
Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2022 TheNewswire - All rights reserved.
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you want a better viewing and privacy experience, join us as Canadian Insider Club Ultra member to eliminate third-party ads